21st week of 2020 patent applcation highlights part 9 |
Patent application number | Title | Published |
20200155433 | SKIN CLEANSING COMPOSITION | 2020-05-21 |
20200155434 | SKIN CLEANSING COMPOSITION | 2020-05-21 |
20200155435 | HAIR COSMETIC | 2020-05-21 |
20200155436 | COMPOSITION CONTAINING QUATERNARY AMMONIUM COMPOUND, ESPECIALLY FOR PRODUCING CARE AND CLEANING FORMULATIONS | 2020-05-21 |
20200155437 | Personal Care Composition | 2020-05-21 |
20200155438 | PHARMACEUTICAL COMPOSITION AND METHOD FOR THE PREVENTION AND TREATMENT OF PATHOLOGIES OF THE ORAL CAVITY | 2020-05-21 |
20200155439 | PERSONAL CARE COMPOSITION | 2020-05-21 |
20200155440 | OIL-IN-WATER EMULSION COSMETIC | 2020-05-21 |
20200155441 | PROCESS FOR MANUFACTURING OMNIPHOBIC COSMETIC PIGMENTS | 2020-05-21 |
20200155442 | SKIN LIGHTENING COMPOSITIONS | 2020-05-21 |
20200155443 | COSMETIC COMPOSITION FOR WHITENING WITH GREEN TOMATO EXTRACTS, BURDOCK ROOT EXTRACTS AND CHICKPEA EXTRACTS | 2020-05-21 |
20200155444 | YEAST-BASED MASKS FOR IMPROVED SKIN, HAIR AND SCALP HEALTH | 2020-05-21 |
20200155445 | AGED ROSE EXTRACT AND PREPARATION METHOD THEREOF | 2020-05-21 |
20200155446 | SELF-REGULATING OSMOTIC GASTRORETENTIVE DRUG DELIVERY SYSTEMS | 2020-05-21 |
20200155447 | ADHERENT ORAL PHARMABIOTIC DELIVERY STRIP | 2020-05-21 |
20200155448 | USE OF IL-22 DIMER IN MANUFACTURE OF A MEDICAMENT FOR INTRAVENOUS ADMINISTRATION | 2020-05-21 |
20200155449 | METHOD FOR MORSELIZING AND/OR TARGETING PHARMACEUTICALLY ACTIVE PRINCIPLES TO SYNOVIAL TISSUE | 2020-05-21 |
20200155450 | PHARMACEUTICAL COMPOSITIONS COMPRISING GELS AND METHODS FOR FABRICATING THEREOF | 2020-05-21 |
20200155451 | DRY POWDER VANCOMYCIN COMPOSITIONS AND ASSOCIATED METHODS | 2020-05-21 |
20200155452 | Cromolyn Compositions for Treatment of Chronic Cough Due to Idiopathic Pulmonary Fibrosis | 2020-05-21 |
20200155453 | Methods for Producing Carboxylate Ligand Modified Ferric Iron Hydroxide Colloids and Related Compositions and Uses | 2020-05-21 |
20200155454 | POLYMER-GRAFTED NANOBINS | 2020-05-21 |
20200155455 | COLD-WATER-DISPERSIBLE CHEMICAL DELIVERY SYSTEM | 2020-05-21 |
20200155456 | USE OF HIGHER DOSES OF MODIFIED RELEASE HUPERZINE FORMULATIONS | 2020-05-21 |
20200155457 | ORAL SOLID PREPARATION COMPOSITION COMPRISING PROTON PUMP INHIBITOR, ORAL SOLID PREPARATION COMPRISING SAME, AND PREPARATION METHOD THEREFOR | 2020-05-21 |
20200155458 | DOSAGE FORM | 2020-05-21 |
20200155459 | TABLET AND METHOD FOR MANUFACTURING THE SAME | 2020-05-21 |
20200155460 | COMPRESSIBLE AND FREE-FLOW CO-AGGLOMERATES OF MANNITOL AND GRANUAL STARCH | 2020-05-21 |
20200155461 | ORAL PHARMACEUTICAL COMPOSITIONS OF NICOTINAMIDE | 2020-05-21 |
20200155462 | COMPRESSED TABLETS | 2020-05-21 |
20200155463 | TABLETS HAVING DISCONTINUOUS COATED REGIONS | 2020-05-21 |
20200155464 | Seamless Capsule Shell Composition and Seamless Capsule | 2020-05-21 |
20200155465 | VAGINAL INSERTED ESTRADIOL PHARMACEUTICAL COMPOSITIONS AND METHODS | 2020-05-21 |
20200155466 | Oral Medicine Delivery Capsule | 2020-05-21 |
20200155467 | METHOD AND SYSTEM FOR PRODUCTION OF SOFTGELS | 2020-05-21 |
20200155468 | ALGINATE MICROCAPSULES FOR CELL AND MOLECULAR THERAPY THAT SECRETE BIOACTIVE IMMUNE MOLECULES | 2020-05-21 |
20200155469 | THERAPEUTIC NANOPARTICLES ENCAPSULATING TERPENOIDS AND/OR CANNABINOIDS | 2020-05-21 |
20200155470 | PECTIN MICROCAPSULES, METHOD FOR THE MANUFACTURE AND USE THEREOF | 2020-05-21 |
20200155471 | Methods and Compositions Particularly for Treatment of Attention Deficit Disorder | 2020-05-21 |
20200155472 | Fabrication of a Suramin-Loaded Nanoparticle and Its Application | 2020-05-21 |
20200155473 | TRANSDERMAL PATCH PACKAGING FILM | 2020-05-21 |
20200155474 | OXYGEN-GENERATING COMPOSITIONS FOR ENHANCING CELL AND TISSUE SURVIVAL IN VIVO | 2020-05-21 |
20200155475 | Transdermal Drug Delivery System | 2020-05-21 |
20200155476 | TRANSDERMAL PATCH | 2020-05-21 |
20200155477 | CLADRIBINE REGIMEN FOR TREATING MULTIPLE SCLEROSIS | 2020-05-21 |
20200155478 | XIBORNOL FOR USE IN THE TREATMENT OF ACNE VULGARIS | 2020-05-21 |
20200155479 | Method for infusing whole coffee beans and Tea Leaves with cannabis (Hemp) ingredients | 2020-05-21 |
20200155480 | METHODS FOR DRUG DELIVERY, TUMOR IMAGING, AND OXIDATIVE DEHYDROGENATION USING HIERARCHICAL ZSM-5 COMPLEX | 2020-05-21 |
20200155481 | INTRAMUSCULAR ATOVAQUONE FOR MALARIA PROPHYLAXIS | 2020-05-21 |
20200155482 | NANOPARTICLES FORMED OF A POLYMER AND TERBINAFINE | 2020-05-21 |
20200155483 | COMBINATION THERAPY FOR THE TREATMENT OF TINNITUS AND OTHER MEDICAL CONDITIONS | 2020-05-21 |
20200155484 | NICLOSAMIDE FOR THE TREATMENT OF CANCER METASTASIS | 2020-05-21 |
20200155485 | NEW ORAL FORMULATIONS OF BELINOSTAT | 2020-05-21 |
20200155486 | Methods of Treatment of inflammation related conditions using pluripotent anti-inflammatory and metabolic Modulators | 2020-05-21 |
20200155487 | Treatment of obesity and its complications | 2020-05-21 |
20200155488 | AUTOIMMUNE DISORDER TREATMENT USING RXR AGONISTS | 2020-05-21 |
20200155489 | AUTOIMMUNE DISORDER TREATMENT USING RXR AGONISTS | 2020-05-21 |
20200155490 | IMMUNOMOUDULATORY AGENTS AND METHODS OF USE THEREOF | 2020-05-21 |
20200155491 | THERAPEUTIC APPROACHES FOR TREATING CMT AND RELATED DISORDERS | 2020-05-21 |
20200155492 | COMPOSITIONS AND METHODS FOR THE TREATMENT OF ZIKA VIRAL DISEASES | 2020-05-21 |
20200155493 | PHARMACEUTICAL COMPOSITION FOR TREATING EXCESSIVE LACTATE PRODUCTION AND ACIDEMIA | 2020-05-21 |
20200155494 | METHOD FOR TREATING IDIOPATHIC PULMONARY FIBROSIS | 2020-05-21 |
20200155495 | PHARMACEUTICAL COMPOSITIONS AND METHODS UTILIZING NEOSTIGMINE AND A NK-1 ANTAGONIST FOR TREATING MYASTHENIA GRAVIS | 2020-05-21 |
20200155496 | Pharmaceutical Compositions of Dimethyl Fumarate | 2020-05-21 |
20200155497 | NOVEL ANTITUMORAL USE OF CABAZITAXEL | 2020-05-21 |
20200155498 | TREATMENT OF CUTANEOUS DISORDERS | 2020-05-21 |
20200155499 | MATERIAL FOR IMPROVING ENDOMETRIOSIS AND METHOD FOR PRODUCING THE SAME | 2020-05-21 |
20200155500 | COMPOSITION FOR PREVENTING AND TREATING PANCREATITIS CONTAINING NAPHTHOQUINONE-BASED COMPOUND AS ACTIVE INGREDIENT | 2020-05-21 |
20200155501 | METHODS AND COMPOSITIONS RELATING TO STEROID HORMONE RECEPTOR-DEPENDENT CANCERS | 2020-05-21 |
20200155502 | COMPOSITIONS AND METHODS FOR PREVENTING AND TREATING RADIATION-INDUCED BYSTANDER EFFECTS CAUSED BY RADIATION OR RADIOTHERAPY | 2020-05-21 |
20200155503 | COMPOSITIONS FOR USE FOR TREATING CUTANEOUS LEISHMANIASIS | 2020-05-21 |
20200155504 | COMPOSITIONS COMPRISING UROLITHINS AND USES THEREOF FOR THE STIMULATION OF INSULIN SECRETION | 2020-05-21 |
20200155505 | AGENT FOR PREVENTING OR TREATING TAUOPATHY | 2020-05-21 |
20200155506 | FORMULATION COMPRISING GLYCOPYRROLATE, METHOD AND APPARATUS | 2020-05-21 |
20200155507 | THERAPEUTIC COMPOUNDS AND METHODS TO TREAT INFECTION | 2020-05-21 |
20200155508 | Carbapenem Compounds and Compositions for the Treatment of Bacterial Infections | 2020-05-21 |
20200155509 | CHEMICAL COMPOUNDS AS ANTIBIOTICS | 2020-05-21 |
20200155510 | TREATMENT OF AUTOIMMUNE DISORDERS, SUCH AS RELAPSING REMITTING MULTIPLE SCLEROSIS AND CLINICALLY ISOLATED SYNDROME WITH BIOTIN COMPOSITIONS | 2020-05-21 |
20200155511 | ISOXAZOLINE-SUBSTITUTED BENZAMIDE COMPOUND AND PESTICIDE | 2020-05-21 |
20200155512 | Compositions and Methods of Treating Cardiac Fibrosis with Ifetroban | 2020-05-21 |
20200155513 | Thromboxane Receptor Antagonists in AERD/Asthma | 2020-05-21 |
20200155514 | PHARMACEUTICAL COMPOSITION | 2020-05-21 |
20200155515 | ALPHA-AMINO ESTERS OF HYDROXYPROPYLTHIAZOLIDINE CARBOXAMIDE DERIVATIVE AND SALT FORM, CRYSTAL POLYMORPH THEREOF | 2020-05-21 |
20200155516 | COMPOSITIONS AND METHODS OF USING (R)-PRAMIPEXOLE | 2020-05-21 |
20200155517 | METHODS AND COMPOSITIONS FOR INCREASING THE EFFECTIVENESS OF ANTIVIRAL AGENTS | 2020-05-21 |
20200155518 | Polymer Derivative Of Macrolide Immunosuppressant | 2020-05-21 |
20200155519 | METHODS FOR TREATING CANCER WITH COMPOSITIONS COMPRISING AMLEXANOX AND IMMUNE MODULATORS | 2020-05-21 |
20200155520 | METHODS OF TREATING CANCER USING B-RAF INHIBITORS AND IMMUNE CHECKPOINT INHIBITORS | 2020-05-21 |
20200155521 | PHARMACEUTICAL COMBINATION FOR TREATMENT OF CANCER | 2020-05-21 |
20200155523 | TREATMENT OF GASTROPARESIS WITH TRIAZASPIRO[4.5]DECANONE | 2020-05-21 |
20200155524 | METHOD FOR REDUCING SIDE EFFECTS FROM ADMINISTRATION OF PHOSPHODIESTERASE-4 INHIBITORS | 2020-05-21 |
20200155525 | 1H-PYRAZOLO[3,4-B]PYRIDINES AND THERAPEUTIC USES THEREOF | 2020-05-21 |
20200155526 | TARGETING LYSINE DEMETHYLASES (KDMS) AS A THERAPEUTIC STRATEGY FOR DIFFUSE LARGE B-CELL LYMPHOMA | 2020-05-21 |
20200155527 | THIAZOLECARBOXAMIDES AND PYRIDINECARBOXAMIDE COMPOUNDS USEFUL AS PIM KINASE INHIBITORS | 2020-05-21 |
20200155528 | Short-Acting Dihydropyridines (Clevidipine) For Use in Reducing Stroke Damage | 2020-05-21 |
20200155529 | METHODS FOR TREATING CARPAL TUNNEL PAIN | 2020-05-21 |
20200155530 | PHARMACEUTICAL COMPOSITIONS AND METHOD UTILIZING PYRIDOSTIGMINE AND A NK-1 ANTAGONIST FOR TREATING MYASTHENIA GRAVIS | 2020-05-21 |
20200155531 | Fumarate Analogs and Uses Thereof | 2020-05-21 |
20200155532 | METHOD FOR TREATING VIRAL INFECTIONS WITH LOPERAMIDE | 2020-05-21 |
20200155533 | METHODS AND COMPOSITIONS FOR TREATMENT OF MITOCHONDRIAL TOXICITY | 2020-05-21 |